The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
Name
Sabatini_The mTOR.pdf
Size
1.67 MB
Format
Adobe PDF
Checksum (MD5)
9f64fbc81a946cdb26a6f2b7a19b5b9f
Author(s)
Rameseder, J.
Zhang, Y.
Ottina, Kathleen
Lim, D.
Choi, Y.
Gray, Nathanael S.
Yaffe, M. B.
Marto, Jarrod A.
Hsu, Peggy P.
Kang, Seong A.
Date Issued
April 2011
Journal
Science
Publisher
American Association for the Advancement of Science (AAAS)
Citation
Hsu, P. P., S. A. Kang, J. Rameseder, Y. Zhang, K. A. Ottina, D. Lim, T. R. Peterson, et al. “The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling.” Science 332, no. 6035 (June 9, 2011): 1317-1322.
Version
Author's final manuscript
Abstract
The mammalian target of rapamycin (mTOR) protein kinase is a master growth promoter that nucleates two complexes, mTORC1 and mTORC2. Despite the diverse processes controlled by mTOR, few substrates are known. We defined the mTOR-regulated phosphoproteome by quantitative mass spectrometry and characterized the primary sequence motif specificity of mTOR using positional scanning peptide libraries. We found that the phosphorylation response to insulin is largely mTOR dependent and that mTOR exhibits a unique preference for proline, hydrophobic, and aromatic residues at the +1 position. The adaptor protein Grb10 was identified as an mTORC1 substrate that mediates the inhibition of phosphoinositide 3-kinase typical of cells lacking tuberous sclerosis complex 2 (TSC2), a tumor suppressor and negative regulator of mTORC1. Our work clarifies how mTORC1 inhibits growth factor signaling and opens new areas of investigation in mTOR biology.
Description
September 21 Author Manuscript
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike 3.0
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1126/science.1199498
